ASAHI KASEI CORPORATION’s after-hours PTS trading price is approximately ¥1,598, down from the previous day. The financial results summary shows substantial increases in sales and profit for the first quarter of the fiscal year ending March 2027, with expansion in the healthcare segment expected following the consolidation of Aicuris after its acquisition.
The after-hours PTS trading price has remained around ¥1,598, slightly below the Tokyo Stock Exchange closing price. Compared with the current real-time quotation, the trading price is down 0.13% from the previous day.
According to the summary of ASAHI KASEI CORPORATION’s financial results for the first quarter of the fiscal year ending March 2027, net sales rose 11.9% year on year to ¥826.2 billion, operating profit increased 51.5% to ¥81.3 billion, and net income climbed 172.7% to ¥53.8 billion, resulting in substantial increases in both sales and profit.
The factors behind this strong performance include the expansion of the healthcare segment following completion of the acquisition of Aicuris, as well as a reduction in extraordinary losses from the same period of the previous year. The consolidation of Aicuris is expected to affect the company’s earnings structure.
Key points to monitor in future results include expanded sales of pharmaceuticals and electronic materials, the sustainability of the consolidation effects, impairment risks related to goodwill and intangible assets, and revisions to cost allocation.